Cancer: Cancer and telomeres - An alternative to telomerase

Jerry W. Shay, Roger R. Reddel, Woodring E. Wright

Research output: Contribution to journalShort survey

79 Scopus citations

Abstract

Finding ways to target the alternative (ALT) telomere lengthening pathway found in some cancer cells could complement telomerase inhibitors currently in clinical trials.

Original languageEnglish (US)
Pages (from-to)1388-1390
Number of pages3
JournalScience
Volume336
Issue number6087
DOIs
StatePublished - Jun 15 2012

    Fingerprint

ASJC Scopus subject areas

  • General

Cite this